Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)

References

• WangXWangZWuLCombined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinomaBMC Surg2016162227094483
   PubMed Web of Science ®Google Scholar
• AitkenKLHawkinsMAThe role of radiotherapy and chemora-diation in the management of primary liver tumoursClin Oncol2014269569580
   PubMed Web of Science ®Google Scholar
• CarrBIGuerraVFeatures of massive hepatocellular carcinomasEur J Gastroenterol Hepatol201426110110823863262
   PubMed Web of Science ®Google Scholar
• VautheyJNLauwersGYEsnaolaNFSimplified staging for hepatocellular carcinomaJ Clin Oncol20022061527153611896101
   PubMed Web of Science ®Google Scholar
• KleinJDawsonLAHepatocellular carcinoma radiation therapy: review of evidence and future opportunitiesInt J Radiat Oncol Biol Phys2013871223223219567
   PubMed Web of Science ®Google Scholar
• CarrBIGuerraVFeatures of massive hepatocellular carcinomasEur J Gastroenterol Hepatol201426110110823863262
   PubMed Web of Science ®Google Scholar
• ChangYJChungKPChangYJChenLJLong-term survival of patients undergoing liver resection for very large hepatocellular carcinomasBr J Surg2016103111513152027550624
   PubMed Web of Science ®Google Scholar
• GiulianteFde RoseAMGuerraVArditoFNuzzoGCarrBIClinical characteristics and survival of European patients with resectable large hepatocellular carcinomasJ Gastrointest Cancer201344332933523912605
   PubMedGoogle Scholar
• ZengZCTangZYFanJA comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinomaCancer J200410530731615530260
   PubMed Web of Science ®Google Scholar
• BoigeVRaoulJLPignonJPMulticentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trialBr J Cancer200797786286717876335
   PubMed Web of Science ®Google Scholar
• ZhuAXBlaszkowskyLSRyanDPPhase II study of gem-citabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinomaJ Clin Oncol200624121898190316622265
   PubMed Web of Science ®Google Scholar
• LencioniRChemoembolization in patients with hepatocellular carcinomaLiver Cancer201211415024159570
   PubMed Web of Science ®Google Scholar
• MurataSMineTSugiharaFInterventional treatment for unresectable hepatocellular carcinomaWorld J Gastroenterol20142037134531346525309076
   PubMed Web of Science ®Google Scholar
• RayCEBrownACGreenTJSurvival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolizationAm J Roentgenol2015204244044725615768
   PubMed Web of Science ®Google Scholar
• de StefanoGIodiceVSignorielloGScognamiglioUFarellaNP1325: Efficacy and safety of combined sequential treatment with RFA and sorafenib in patients with HCC in intermediate stage ineligible for TACE: A prospective randomized open studyJ Hepatol201562S852S852
   Web of Science ®Google Scholar
• VeltriAMorettoPDoriguzziAPaganoECarraraGGandiniGRadiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)Eur Radiol200616366166916228211
   PubMed Web of Science ®Google Scholar
• KadalayilLBeniniRPallanLA simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnn Oncol201324102565257023857958
   PubMed Web of Science ®Google Scholar
• CilloUVitaleAGrigolettoFProspective validation of the Barcelona Clinic Liver Cancer staging systemJ Hepatol200644472373116488051
   PubMed Web of Science ®Google Scholar
• LiapiEGeschwindJFChemoembolization for primary and metastatic liver cancerCancer J201016215616220404613
   PubMed Web of Science ®Google Scholar
• SunHNiJJiangXThe effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCTOnco Targets Ther2017103835384228814882
   PubMed Web of Science ®Google Scholar
• SekiTWakabayashiMNakagawaTUltrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinomaCancer19947438178258039109
   PubMed Web of Science ®Google Scholar
• YinXYXieXYLuMDPercutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factorsCancer200911591914192319241423
   PubMed Web of Science ®Google Scholar
• XuLFSunHLChenYTLarge primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapyJ Gastroenterol Hepatol201328345646323216261
   PubMed Web of Science ®Google Scholar
• Hernández-GuerraMHernández-CambaATurnesJApplication of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survivalUnited European Gastroenterol J201533284293
   PubMed Web of Science ®Google Scholar
• PrajapatiHJKimHSTreatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolizationPLoS One2017122e017075028170405
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of CUpdated standards for the diagnosis and treatment of primary liver cancerZhonghua Gan Zang Bing Za Zhi201220419426 Chinese23230592
   PubMedGoogle Scholar
• XieLLSunCJLiXDWangYHWangCEArterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin spongeIndian J Cancer201551Suppl 24951
   Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• FattovichGGiustinaGDegosFMorbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsGastroenterology199711224634729024300
   PubMed Web of Science ®Google Scholar
• CarrBIGuerraVPancoskaPThrombocytopenia in relation to tumor size in patients with hepatocellular carcinomaOncology201283633934523006937
   PubMed Web of Science ®Google Scholar
• SekiTWakabayashiMNakagawaTUltrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinomaCancer19947438178258039109
   PubMed Web of Science ®Google Scholar
• SekiTTamaiTNakagawaTCombination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinomaCancer20008961245125111002219
   PubMed Web of Science ®Google Scholar
• NomuraFOhnishiKTanabeYClinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer1989648170017072477133
   PubMed Web of Science ®Google Scholar
• TangkijvanichPAnukulkarnkusolNSuwangoolPClinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levelsJ Clin Gastroenterol200031430230811129271
   PubMed Web of Science ®Google Scholar
• ChoiDLimHKRhimHPercutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factorsAnn Surg Oncol20071482319232917522947
   PubMed Web of Science ®Google Scholar
• CarrBIGuerraVGianniniEGLow alpha-fetoprotein HCC and the role of GGTPInt J Biol Markers2014294395402
   Web of Science ®Google Scholar
• BlankSWangQFielMIAssessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normalAnn Surg Oncol201421398699424232510
   PubMed Web of Science ®Google Scholar
• TerentievAAMoldogazievaNTAlpha-fetoprotein: a renaissanceTumour Biol20133442075209123765762
   PubMedGoogle Scholar
• BholeeAKPengKZhouZRadiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control studyClin Transl Oncol201719784485228070766
   PubMed Web of Science ®Google Scholar
• ChoiYHChungJWSonKRNovel intraarterial therapy for liver cancer using ethylbromopyruvate dissolved in an iodized oilAcad Radiol201118447147821237678
   PubMed Web of Science ®Google Scholar
• PaulSBGamanagattiSRGuptaAKTumor size determines the outcome of trans-arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): ongoing work at a tertiary care centre in IndiaJ Gastroen Hepatol201025A100A100
   Web of Science ®Google Scholar
• NhuQKnowlesHPockrosPFrenetteCAn Unexpected Pulmonary Complication Following TACE With Low-Dose Doxorubicin-Eluting Beads and Small-Volume Lipiodol for a Small HCCAm J Gastroen-terol2015110S345S346
   Web of Science ®Google Scholar
• GoelAFidelmanNYaoFRobertsJTerraultNPre-Transplant Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma (HCC) and Risk of Hepatic Artery Complications (HA-C) in Liver Transplant (LT) RecipientsLiver Transplant201218S256S256
   Web of Science ®Google Scholar